100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]

RxCUI: 1986389
RxNorm name: 100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]
Display name: CLINOLIPID (Injectable)
Full name: 100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]
Term type: SBD
Status: Active
Strength: 160-40 mg/ml
Dose form: Injection 100 ml
Route: Injectable
Updated: 2026-11-02 22:16:32

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 112017
Active start: 112017
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
olive oil	160 MG / 1 ML	olive oil	olive oil
soybean oil	40 MG / 1 ML	soybean oil	soybean oil

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Injection	1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
olive oil	1309250
soybean oil	9949

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Clinolipid 20 % per 100 ML Injection	1	NAMES
RxNorm Name	100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]	1	NAMES
RxNorm Synonym	Clinolipid 20 % per 100 ML Injection	1	NAMES
TTY	SBD	1	ATTRIBUTES
SPL_SET_ID	ae98eb03-c0e7-49d1-b024-77968e3d9d6e	1	CODES
RxCUI	1986389	1	CODES
MMSL_CODE	MTH_RXN_BD41355	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0338-9540-05	0338-9540	Clinolipid Olive Oil and Soybean Oil	Baxter Healthcare Corporation	NDA204508

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
NDA204508	0338-9540	Clinolipid Olive Oil and Soybean Oil	NDA	Baxter Healthcare Corporation

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00338954001	rxnav_ndcs	yes
00338954005	rxnav_ndcs	yes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Clinolipid	OLIVE OIL AND SOYBEAN OIL	Baxter Healthcare Corporation	ae98eb03-c0e7-49d1-b024-77968e3d9d6e	2025-07-24	Warnings, Adverse reactions	Exact identifier ndc (package): 0338-9540-05 ndc (product): 0338-9540 ndc11 (package): 00338954005 ndc11 (package): 00338954001 rxcui: 1986389

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
ae98eb03-c0e7-49d1-b024-77968e3d9d6e	Clinolipid 20 % in 100 mL Injection [PSN] · 100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid] [SBD] · Clinolipid 20 % per 100 ML Injection [SY]	3	23	These highlights do not include all the information needed to use CLINOLIPID safely and effectively. See full prescribing information for CLINOLIPID. CLINOLIPID (lipid injectable emulsion), for intravenous use Initial U.S. Approval: 1975	20250724

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
ae98eb03-c0e7-49d1-b024-77968e3d9d6e	These highlights do not include all the information needed to use CLINOLIPID safely and effectively. See full prescribing information for CLINOLIPID. CLINOLIPID (lipid injectable emulsion), for intravenous use Initial U.S. Approval: 1975	Baxter Healthcare Corporation \| Baxter SA \| Baxter R&D Europe SPRL	20250724
ae98eb03-c0e7-49d1-b024-77968e3d9d6e	These highlights do not include all the information needed to use CLINOLIPID safely and effectively. See full prescribing information for CLINOLIPID. CLINOLIPID (lipid injectable emulsion), for intravenous use Initial U.S. Approval: 1975	Baxter Healthcare Corporation \| Baxter SA \| Baxter R&D Europe SPRL	20250724
ae98eb03-c0e7-49d1-b024-77968e3d9d6e	These highlights do not include all the information needed to use CLINOLIPID safely and effectively. See full prescribing information for CLINOLIPID. CLINOLIPID (lipid injectable emulsion), for intravenous use Initial U.S. Approval: 1975	Baxter Healthcare Corporation \| Baxter SA \| Baxter R&D Europe SPRL	20250724
ae98eb03-c0e7-49d1-b024-77968e3d9d6e	These highlights do not include all the information needed to use CLINOLIPID safely and effectively. See full prescribing information for CLINOLIPID. CLINOLIPID (lipid injectable emulsion), for intravenous use Initial U.S. Approval: 1975	Baxter Healthcare Corporation \| Baxter SA \| Baxter R&D Europe SPRL	20240724

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
FDASPL	D008055	Lipids	CHEM	has_chemical_structure	olive oil
FDASPL	D008055	Lipids	CHEM	has_chemical_structure	soybean oil
FDASPL	N0000191261	Lipid Emulsion	EPC	has_epc	soybean oil
FDASPL	N0000191261	Lipid Emulsion	EPC	has_epc	olive oil
MEDRT	D000069463	Olive Oil	CHEM	has_ingredient	olive oil
MEDRT	D013024	Soybean Oil	CHEM	has_ingredient	soybean oil
MEDRT	D006967	Hypersensitivity	DISEASE	may_treat	soybean oil
MEDRT	D044342	Malnutrition	DISEASE	may_treat	soybean oil
MEDRT	D009402	Nephrosis, Lipoid	DISEASE	ci_with	soybean oil
MEDRT	D010195	Pancreatitis	DISEASE	ci_with	soybean oil
MEDRT	N0000000082	Immunologic Factor Interactions	MOA	has_moa	soybean oil
MEDRT	N0000175374	Peroxisome Proliferator-activated Receptor Activity	MOA	has_moa	soybean oil
MEDRT	N0000184306	Cell-mediated Immunity	PE	has_pe	soybean oil
MEDRT	N0000175629	Increased Histamine Release	PE	has_pe	soybean oil
MEDRT	N0000185001	Increased IgG Production	PE	has_pe	soybean oil
MEDRT	N0000182157	Increased T Lymphocyte Activation	PE	has_pe	soybean oil
MEDRT	N0000009895	Triglyceride Metabolism Alteration	PE	has_pe	soybean oil

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Clinolipid	rxnav_allrelated
DF	DF	Injection	rxnav_allrelated
DFG	DFG	Injectable Product	rxnav_allrelated
IN	IN	olive oil	rxnav_allrelated
IN	IN	soybean oil	rxnav_allrelated
MIN	MIN	olive oil / soybean oil	rxnav_allrelated
SBD	SBD	100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]	rxnav_allrelated
SBDC	SBDC	olive oil 160 MG/ML / soybean oil 40 MG/ML [Clinolipid]	rxnav_allrelated
SBDF	SBDF	olive oil / soybean oil Injection [Clinolipid]	rxnav_allrelated
SBDG	SBDG	Clinolipid Injectable Product	rxnav_allrelated
SCD	SCD	100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection	rxnav_allrelated
SCDC	SCDC	olive oil 160 MG/ML	rxnav_allrelated
SCDC	SCDC	soybean oil 40 MG/ML	rxnav_allrelated
SCDF	SCDF	olive oil / soybean oil Injection	rxnav_allrelated
SCDG	SCDG	olive oil / soybean oil Injectable Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	160 MG/ML / 40 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	QUANTITY	100 ML
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	NDA	NDA204508
CODES	VUID	4038685
NAMES	Prescribable Synonym	Clinolipid 20 % in 100 mL Injection
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	Veterans Health Administration National Drug File